Acute inflammation when """"""""uncontrolled"""""""" can lead, as in the event of bioterrorist attacks, to massive threat to individual life and undue risk to public health. Human neutrophils (PMN) play pivotal roles in acute inflammation and periodontal disease (PD)-associated tissue injury by releasing lipid-derived mediators (LM) and pro-inflammatory products that affect both tissue integrity and oral function. New evidence has emerged from the PI's laboratory and work in progress indicating that control of PMN during resolution is an active process with the identification in exudates of potent novel protective LM termed resolvins (RV) and docosatrienes (DT) generated by PMN that reduce acute inflammation and PMN-mediated tissue injury. From these findings, it is now clear that the molecular map of resolution, an important homeostatic process, remains largely uncharted. The focus of sub-project 0001 in this multi-disciplinary Specialized Center for Research is on systematic elucidation of novel pro-resolving circuits using lipidomics coupled with proteomics. Sub-Project 0001 will test the hypothesis that LM, including RV, DT, and their aspirin-triggered epimers, regulate endogenous anti-inflammatory circuits that govern leukocyte traffic and key molecular events required for resolution. Disruption of these novel resolution circuits by microbial products and widely used treatments in oral surgical practices (local anesthetics, NSAIDs) prolongs tissue inflammation. To test this, 3 specific aims are proposed:
Aim 1 will establish the formation and role of LM and molecular circuitry of resolution in murine peritonitis compared to PD with the directive of translating identified resolution components to humans via Core 9002. Experiments in Aim 2 are designed to identify the LM receptors involved in resolution of PD using genetically engineered mice, and labeled-RV and DT with both human PMN and recombinant receptors.
Aim 3 will determine the impact of microbe products, current anti-inflammatories, and local analgesics in timely resolution. The broad long-term goals are two-fold: 1) elucidate the human map of oral resolution and associated genes evoked during microbial defense and PMN-mediated tissue injury in PD, and 2)provide map(s) with molecular coordinates of resolution to oral surgeons and dentists to improve current treatment practices and preparedness for bioterrorist attacks.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE016191-05
Application #
7676062
Study Section
Special Emphasis Panel (ZDE1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$305,144
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Van Dyke, T E; Hasturk, H; Kantarci, A et al. (2015) Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res 94:148-56
Winkler, Jeremy W; Uddin, Jasim; Serhan, Charles N et al. (2013) Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer. Org Lett 15:1424-7
Gao, Li; Faibish, Dan; Fredman, Gabrielle et al. (2013) Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol 190:689-94
Bartold, P Mark; Van Dyke, Thomas E (2013) Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 62:203-17
Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E (2012) Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol 3:118
Petasis, Nicos A; Yang, Rong; Winkler, Jeremy W et al. (2012) Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer. Tetrahedron Lett 53:1695-1698
Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E (2012) Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 15:160-76
Serhan, Charles N; Petasis, Nicos A (2011) Resolvins and protectins in inflammation resolution. Chem Rev 111:5922-43
Levy, Bruce D; Zhang, Qing-yin; Bonnans, Caroline et al. (2011) The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot Essent Fatty Acids 84:43-50
Uddin, Mohib; Levy, Bruce D (2011) Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 50:75-88

Showing the most recent 10 out of 139 publications